B\u00e2le, le 6 mai 2021 <\/p>\n\n\n\n
De l\u2019avis d\u2019Interpharma, la d\u00e9cision du gouvernement des \u00c9tats-Unis de s\u2019engager aupr\u00e8s de l\u2019OMC pour une suspension des brevets pour les vaccins contre la COVID-19 est d\u00e9cevante et n\u2019atteindra pas le but recherch\u00e9. C\u2019est une fausse solution \u00e0 un probl\u00e8me complexe et met en danger de futures innovations.<\/p>\n\n\n\n
L\u2019acc\u00e8s aux vaccins rapide et \u00e9quitable pour tous dans le monde entier\nest une priorit\u00e9 pleinement partag\u00e9e par Interpharma. Mais la lev\u00e9e des brevets\nn\u2019est pas la bonne solution. Renoncer aux brevets pour les vaccins contre la\nCOVID-19 ne contribue ni \u00e0 accro\u00eetre la production, ni \u00e0 r\u00e9soudre les probl\u00e8mes\npratiques qui se posent dans la lutte contre cette crise sanitaire mondiale.<\/p>\n\n\n\n
Ren\u00e9 Buholzer, directeur d\u2019Interpharma, d\u00e9clare \u00e0 ce sujet:<\/p>\n\n\n\n
Dans la crise actuelle, lever les droits de la propri\u00e9t\u00e9 intellectuelle n\u2019aurait aucun effet sur la fabrication \u00e0 grande \u00e9chelle et la distribution \u00e9quitable de vaccins, produits diagnostiques et m\u00e9dicaments. Au contraire, la protection de la propri\u00e9t\u00e9 intellectuelle est le garant de l\u2019innovation et a fait ses preuves pour le transfert de technologies entre les entreprises. Lever la protection conf\u00e9r\u00e9e par les brevets affaiblirait de mani\u00e8re d\u00e9cisive la r\u00e9ponse de la communaut\u00e9 scientifique aux mutations et aux futures pand\u00e9mies.<\/em><\/p><\/blockquote>\n\n\n\n
Affaiblissement des cha\u00eenes\nd\u2019approvisionnement et de la qualit\u00e9<\/strong><\/strong><\/h2>\n\n\n\n
Cette initiative ne r\u00e9sout pas le v\u00e9ritable goulet d\u2019\u00e9tranglement qui\nest la disponibilit\u00e9 de capacit\u00e9s de production, de personnel qualifi\u00e9 et de\nmati\u00e8res premi\u00e8res. Au contraire, elle a plut\u00f4t pour effet de d\u00e9tourner l\u2019attention\ndes v\u00e9ritables d\u00e9fis li\u00e9s \u00e0 l\u2019augmentation de la production et de la\ndistribution des vaccins contre la COVID-19: \u00e0 savoir la suppression des\nbarri\u00e8res commerciales, l\u2019\u00e9limination des goulets d\u2019\u00e9tranglement de la cha\u00eene\nd\u2019approvisionnement et la p\u00e9nurie de mati\u00e8res premi\u00e8res et d\u2019ingr\u00e9dients. En\nrenon\u00e7ant aux brevets, on risque de d\u00e9tourner les mati\u00e8res premi\u00e8res et les\nexcipients de cha\u00eenes d\u2019approvisionnement efficaces et bien \u00e9tablies vers des\ninstallations de production moins efficaces o\u00f9 la productivit\u00e9 et la qualit\u00e9\npeuvent poser probl\u00e8me. <\/p>\n\n\n\n
Les vaccins actuellement autoris\u00e9s reposent sur des technologies dont\nla recherche et le d\u00e9veloppement de longue haleine ont \u00e9t\u00e9 rendus possibles par\nla bonne protection de la propri\u00e9t\u00e9 intellectuelle qui existe \u00e0 ce jour. Cela a\npermis aux entreprises de collaborer et de partager les connaissances entre\nchercheurs de mani\u00e8re in\u00e9dite.<\/p>\n","protected":false},"excerpt":{"rendered":"
B\u00e2le, le 6 mai 2021 De l\u2019avis d\u2019Interpharma, la d\u00e9cision du gouvernement des \u00c9tats-Unis de s\u2019engager aupr\u00e8s de l\u2019OMC pour une suspension des brevets pour les vaccins contre la COVID-19 est d\u00e9cevante et n\u2019atteindra pas le but recherch\u00e9. C\u2019est une fausse solution \u00e0 un probl\u00e8me complexe et met en danger de futures innovations. L\u2019acc\u00e8s aux […]<\/p>\n","protected":false},"author":1,"featured_media":14169,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[122],"class_list":["post-13277","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-communique-de-presse"],"acf":[],"yoast_head":"\n
Communiqu\u00e9 de presse: La suspension des brevets est une fausse solution - Interpharma<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: La suspension des brevets est une fausse solution - Interpharma\" \/>\n<meta property=\"og:description\" content=\"B\u00e2le, le 6 mai 2021 De l\u2019avis d\u2019Interpharma, la d\u00e9cision du gouvernement des \u00c9tats-Unis de s\u2019engager aupr\u00e8s de l\u2019OMC pour une suspension des brevets pour les vaccins contre la COVID-19 est d\u00e9cevante et n\u2019atteindra pas le but recherch\u00e9. C\u2019est une fausse solution \u00e0 un probl\u00e8me complexe et met en danger de futures innovations. L\u2019acc\u00e8s aux […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-06T11:56:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T10:00:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2026\/02\/blog-image-074-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1629\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3\"},\"headline\":\"Communiqu\u00e9 de presse: La suspension des brevets est une fausse solution\",\"datePublished\":\"2021-05-06T11:56:34+00:00\",\"dateModified\":\"2026-03-03T10:00:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/\"},\"wordCount\":443,\"image\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2026\/02\/blog-image-074-scaled.jpg\",\"keywords\":[\"Communiqu\u00e9 de presse\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2021\",\"copyrightHolder\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/\",\"url\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/\",\"name\":\"Communiqu\u00e9 de presse: La suspension des brevets est une fausse solution - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2026\/02\/blog-image-074-scaled.jpg\",\"datePublished\":\"2021-05-06T11:56:34+00:00\",\"dateModified\":\"2026-03-03T10:00:52+00:00\",\"author\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3\"},\"breadcrumb\":{\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#primaryimage\",\"url\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2026\/02\/blog-image-074-scaled.jpg\",\"contentUrl\":\"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2026\/02\/blog-image-074-scaled.jpg\",\"width\":2560,\"height\":1629,\"caption\":\"Closeup of medicine vial or flu, measles vaccine bottle with syringe and needle for immunization on vintage medical background, medicine and drug concept\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: La suspension des brevets est une fausse solution\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#website\",\"url\":\"https:\/\/iph-multisite.berta-bewegt.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/iph-multisite.berta-bewegt.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/iph-multisite.berta-bewegt.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: La suspension des brevets est une fausse solution - Interpharma","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: La suspension des brevets est une fausse solution - Interpharma","og_description":"B\u00e2le, le 6 mai 2021 De l\u2019avis d\u2019Interpharma, la d\u00e9cision du gouvernement des \u00c9tats-Unis de s\u2019engager aupr\u00e8s de l\u2019OMC pour une suspension des brevets pour les vaccins contre la COVID-19 est d\u00e9cevante et n\u2019atteindra pas le but recherch\u00e9. C\u2019est une fausse solution \u00e0 un probl\u00e8me complexe et met en danger de futures innovations. L\u2019acc\u00e8s aux […]","og_url":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/","og_site_name":"Interpharma","article_published_time":"2021-05-06T11:56:34+00:00","article_modified_time":"2026-03-03T10:00:52+00:00","og_image":[{"width":2560,"height":1629,"url":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2026\/02\/blog-image-074-scaled.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#article","isPartOf":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/"},"author":{"name":"berta_admin","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3"},"headline":"Communiqu\u00e9 de presse: La suspension des brevets est une fausse solution","datePublished":"2021-05-06T11:56:34+00:00","dateModified":"2026-03-03T10:00:52+00:00","mainEntityOfPage":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/"},"wordCount":443,"image":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#primaryimage"},"thumbnailUrl":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2026\/02\/blog-image-074-scaled.jpg","keywords":["Communiqu\u00e9 de presse"],"inLanguage":"fr-FR","copyrightYear":"2021","copyrightHolder":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/","url":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/","name":"Communiqu\u00e9 de presse: La suspension des brevets est une fausse solution - Interpharma","isPartOf":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#primaryimage"},"image":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#primaryimage"},"thumbnailUrl":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2026\/02\/blog-image-074-scaled.jpg","datePublished":"2021-05-06T11:56:34+00:00","dateModified":"2026-03-03T10:00:52+00:00","author":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3"},"breadcrumb":{"@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#primaryimage","url":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2026\/02\/blog-image-074-scaled.jpg","contentUrl":"https:\/\/iph-multisite.berta-bewegt.ch\/wp-content\/uploads\/2026\/02\/blog-image-074-scaled.jpg","width":2560,"height":1629,"caption":"Closeup of medicine vial or flu, measles vaccine bottle with syringe and needle for immunization on vintage medical background, medicine and drug concept"},{"@type":"BreadcrumbList","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/blog\/medienmitteilung-ein-aussetzen-der-patentrechte-ist-keine-loesung\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: La suspension des brevets est une fausse solution"}]},{"@type":"WebSite","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#website","url":"https:\/\/iph-multisite.berta-bewegt.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/iph-multisite.berta-bewegt.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/iph-multisite.berta-bewegt.ch\/#\/schema\/person\/749c3574947ecc016332eb58d91e45a3","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/iph-multisite.berta-bewegt.ch"]}]}},"_links":{"self":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts\/13277","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/comments?post=13277"}],"version-history":[{"count":1,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts\/13277\/revisions"}],"predecessor-version":[{"id":13278,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/posts\/13277\/revisions\/13278"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/media\/14169"}],"wp:attachment":[{"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/media?parent=13277"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iph-multisite.berta-bewegt.ch\/fr\/wp-json\/wp\/v2\/tags?post=13277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}